FDA OTC IBUPROFEN APPROVAL ON ASSURANCE FROM WHITEHALL AND BRISTOL-MYERS FOR HYPERSENSITIVITY WARNING EXCEEDED AGENCY AUTHORITY, McNEIL SAYS IN SUIT